Geographical distribution of the Cryptococcus gattii species complex: a systematic review.
Journal
The Lancet. Microbe
ISSN: 2666-5247
Titre abrégé: Lancet Microbe
Pays: England
ID NLM: 101769019
Informations de publication
Date de publication:
24 Aug 2024
24 Aug 2024
Historique:
received:
24
01
2024
revised:
04
06
2024
accepted:
06
06
2024
medline:
28
8
2024
pubmed:
28
8
2024
entrez:
27
8
2024
Statut:
aheadofprint
Résumé
The taxonomy of the Cryptococcus gattii species complex continues to evolve, and has been divided into five pathogenic species. The objective of this systematic review was to summarise the geographical distribution of the C gattii species complex and the species within the C gattii species complex. We searched PubMed for articles related to human, animal, ecological, or laboratory-based studies of C gattii species complex isolates with traceable geographical origin published from January, 1970, until September, 2021. Having extracted their geographical origin, we used ArcMap to construct maps according to the highest degree of resolution allowed by their reported taxonomy, to reflect the most likely area of transmission on the basis of published reports of human isolates. 604 such articles were included in the study. This review indicated that although C gattii species complex isolates have been reported globally, understanding their heterogeneous geographical distribution by species can have implications for researchers and clinicians in formulating research questions and considering diagnostic quandaries.
Identifiants
pubmed: 39191262
pii: S2666-5247(24)00161-7
doi: 10.1016/S2666-5247(24)00161-7
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
100921Informations de copyright
Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests FH is the Vice President of the International Society for Human and Animal Mycology, treasurer of the Netherlands Society for Medical Mycology, chair of the Royal Netherlands Society for Microbiology, Microbial Genomic Division, and received molecular diagnostic kits from Bruker Molecular Diagnostics. NCB was the Data and Safety Monitoring Board chair for NCT04335123. All other authors declare no conflicts of interest.